Bio Green Med Solution BGMS
NASDAQ BGMS
$0.87 +0.04 (+4.50%)
As of: Sep 3, 2026 · 12:10 PM EDT

Bio Green Med Solution (BGMS) Change in Receivables (2025 - 2026)

Bio Green Med Solution (BGMS) posted quarterly Change in Receivables of -$69000.0 for Q1 2026, down 112.97% quarter-over-quarter from $532000.0 in Q4 2025.

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo
Analysis

Bio Green Med Solution (BGMS) Change in Receivables (2025 - 2026) Analysis & Trends

Bio Green Med Solution (BGMS) has reported Change in Receivables for 2 consecutive years, with -$69000.0 the latest figure, recorded in Q1 2026.

Peer Set

Peer Comparison

All peers
# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Receivables (Qtr)
1 Vertex Pharmaceuticals 141.44 Bn 133.58 Bn 2.84 Bn 140.20 Mn
2 Regeneron Pharmaceuticals 86.65 Bn 78.66 Bn 3.93 Bn 838.50 Mn
3 Argenx Se 65.10 Bn 59.92 Bn 1.37 Bn -
4 Moderna 57.10 Bn 51.97 Bn 52.00 Mn -53.00 Mn
5 Revolution Medicines 44.60 Bn 44.60 Bn - -
6 BeOne Medicines 40.40 Bn 35.31 Bn 1.53 Bn 117.58 Mn
7 Alnylam Pharmaceuticals 35.48 Bn 32.17 Bn 992.69 Mn 31.60 Mn
8 Royalty Pharma 28.13 Bn 27.30 Bn - -
9 Insmed 27.46 Bn 26.30 Bn 358.27 Mn 37.16 Mn
10 Bio Green Med Solution 4.87 Mn 1.08 Mn 79,000.00 -114,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -114,000.00
Mar 31, 2026 -69,000.00
Dec 31, 2025 532,000.00